| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Investments | 2,000 | 2,000 | ||
| Long-term prepaid expenses and other assets | 5,551 | - | ||
| Total assets | 372,675 | 388,893 | ||
| Accumulated other comprehensive loss | -4,587 | -4,577 | ||
| Total stockholders deficit | -35,844 | -2,527 | ||
| Total liabilities and stockholders deficit | 372,675 | 388,893 | ||
Cartesian Therapeutics, Inc. (RNAC)
Cartesian Therapeutics, Inc. (RNAC)